Meeting
2020 ASCO Virtual Scientific Program
STAG2-mutated AML patients: ASXL1 cohesin binding motif status and mutation landscape.
Authors
Frank J Scarpa
NeoGenomics Laboratories, Aliso Viejo, CA
Frank J Scarpa , Madhuri Paul , Wendy A Wolfson , Lawrence M. Weiss , Vincent Anthony Funari , Forrest Blocker
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies
Sub Track
Acute Leukemia
Citation
J Clin Oncol 38: 2020 (suppl; abstr 7538)
DOI
10.1200/JCO.2020.38.15_suppl.7538
Abstract #
7538
Poster Bd #
311
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Mutational landscape and clinical characterization of over 17,000 patients with myeloid malignancies using real-world data.
First Author: Taylor J. Jensen
Poster
2023 ASCO Quality Care Symposium
CHIPping in: Clonal hematopoiesis clinics in community oncology.
First Author: Michael Byrne
Poster
2023 ASCO Annual Meeting
A step toward genomic equity: Mutational profiling of patients with myeloid neoplasm in the largest minority-serving hospital in metropolitan Chicago.
First Author: Maha AT Elsebaie
Poster
2023 ASCO Annual Meeting
Clinical and molecular characteristics of patients with AML with an exceptional response to ivosidenib.
First Author: Justin M. Watts